Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation
- PMID: 21277760
- PMCID: PMC3070849
- DOI: 10.1016/j.coi.2011.01.001
Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation
Abstract
Phosphoinositide 3-kinase (PI3K) defines a family of lipid kinases that direct a wide range of cellular processes and cell fate decisions. Since its discovery, and that of its enzymatic antagonist PTEN, much of the focus on PI3K has been on its oncogenic potential. In recent years, studies on PI3K signaling in B lymphocytes have established the importance of this pathway in effecting B cell differentiation and associated molecular events such as V(D)J recombination and class switch recombination. Intriguing new findings also indicate that there is specificity in the PI3K pathway in B cells, including preferential expression or usage of particular PI3K isoforms and counter-regulation by the PTEN and SHIP phosphatases. The role of PI3K adaptor proteins (CD19, BCAP, and TC21) has also undergone revision to reflect both shared and unique properties. The emergence of Foxo1 as a critical PI3K regulatory target for B cell differentiation has united membrane proximal regulatory events orchestrated by PI3K/PTEN/SHIP with key transcriptional targets. Insights into the regulation and impact of PI3K signaling have been brought to bear in new treatments for B cell malignancies, and will also be an important topic of consideration for B cell-dependent autoimmune diseases.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures
References
-
-
Chen J, Limon JJ, Blanc C, Peng SL, Fruman DA. Foxo1 regulates marginal zone B-cell development. European Journal of Immunology. 2010;40:1890–1896. The authors show that loss of Foxo1 leads to enhanced marginal zone B cell formation and recovery of this population in CD19−/− mice, supporting the view that inactivation of Foxo1 is a critical component of CD19-dependent PI3K activation in this B cell subset.
-
-
- Denley A, Kang S, Karst U, Vogt PK. Oncogenic signaling of class I PI3K isoforms. Oncogene. 2007;27:2561–2574. - PubMed
-
- Carracedo A, Pandolfi PP. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene. 2008;27:5527–5541. - PubMed
-
- Leslie NR, Downes CP. PTEN: The down side of PI 3-kinase signalling. Cell Signal. 2002;14:285–295. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
